Clinical Trial Update: Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan [Phase 1]

View source ↗

Summary

Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with solid tumors; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Camptosar (irinotecan)
• Platinol (cisplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: University of New Mexico | Conditions: Solid Tumors, Cancer | Phase 1 | Status: COMPLETED